Search

Your search keyword '"Glycation End Products, Advanced administration & dosage"' showing total 133 results

Search Constraints

Start Over You searched for: Descriptor "Glycation End Products, Advanced administration & dosage" Remove constraint Descriptor: "Glycation End Products, Advanced administration & dosage"
133 results on '"Glycation End Products, Advanced administration & dosage"'

Search Results

1. Dietary galactose exacerbates autoimmune neuroinflammation via advanced glycation end product-mediated neurodegeneration.

2. A 4-Week Diet Low or High in Advanced Glycation Endproducts Has Limited Impact on Gut Microbial Composition in Abdominally Obese Individuals: The deAGEing Trial.

3. Habitual intake of dietary advanced glycation end products is not associated with generalized microvascular function-the Maastricht Study.

4. Homeostasis effects of fermented Maillard reaction products by Lactobacillus gasseri 4M13 in dextran sulfate sodium-induced colitis mice.

5. The advanced glycation end-products (AGEs)/ROS/NLRP3 inflammasome axis contributes to delayed diabetic corneal wound healing and nerve regeneration.

6. Experimental Animal Studies Support the Role of Dietary Advanced Glycation End Products in Health and Disease.

7. A Potential Role for Fructosamine-3-Kinase in Cataract Treatment.

8. Dietary phenotype and advanced glycation end-products predict WTC-obstructive airways disease: a longitudinal observational study.

9. The impact of low advanced glycation end products diet on obesity and related hormones: a systematic review and meta-analysis.

10. Long Term Dietary Restriction of Advanced Glycation End-Products (AGEs) in Older Adults with Type 2 Diabetes Is Feasible and Efficacious-Results from a Pilot RCT.

11. Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study.

12. The glycation level of milk protein strongly modulates post-prandial lysine availability in humans.

13. Advanced Glycation End Products and Receptor (RAGE) Promote Wound Healing of Human Corneal Epithelial Cells.

14. Gut Microbiota Modulation by Dietary Barley Malt Melanoidins.

15. High Dietary Advanced Glycation End Products Impair Mitochondrial and Cognitive Function.

16. Adverse Effects of Autoclaved Diets on the Progression of Chronic Kidney Disease and Chronic Kidney Disease-Mineral Bone Disorder in Rats.

17. Effect of reducing dietary advanced glycation end products on obesity-associated complications: a systematic review.

18. Acute exposure to glycated proteins reduces cardiomyocyte contractile capacity.

19. Metabolic and renal effects of dietary advanced glycation end products in pregnant rats - a pilot study.

20. The Association of Nutritional Factors and Skin Autofluorescence in Persons Receiving Hemodialysis.

21. Glycated proteins in nutrition: Friend or foe?

22. Formula derived Maillard reaction products in post-weaning intrauterine growth-restricted piglets induce developmental programming of hepatic oxidative stress independently of microRNA-21 and microRNA-155.

23. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.

24. In vitro membrane damage induced by half-fin anchovy hydrolysates/glucose Maillard reaction products and the effects on oxidative status in vivo.

25. Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction.

26. Disparity in the micronutrient content of diets high or low in advanced glycation end products (AGEs) does not explain changes in insulin sensitivity.

27. High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes.

28. Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death.

29. Modifications in bacterial groups and short chain fatty acid production in the gut of healthy adult rats after long-term consumption of dietary Maillard reaction products.

30. Dietary Reduction of Advanced Glycation End Products: An Opportunity for Improved Nutrition Care.

31. Consumption of diets with low advanced glycation end products improves cardiometabolic parameters: meta-analysis of randomised controlled trials.

32. Hormetic modulation of hepatic insulin sensitivity by advanced glycation end products.

33. Angiotensin II promotes the anticoagulant effects of rivaroxaban via angiotensin type 2 receptor signaling in mice.

34. Hydrogen sulfide reduces RAGE toxicity through inhibition of its dimer formation.

35. Potential involvement of dietary advanced glycation end products in impairment of skeletal muscle growth and muscle contractile function in mice.

36. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.

37. In vivo imaging of advanced glycation end products (AGEs) of albumin: first observations of significantly reduced clearance and liver deposition properties in mice.

38. Inhibitory effects of advanced glycation end-products and Porphyromonas gingivalis lipopolysaccharide on the expression of osteoblastic markers of rat bone marrow cells in culture.

39. Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial.

40. Soluble receptor for advanced glycation end-products protects against ischemia/reperfusion-induced myocardial apoptosis via regulating the ubiquitin proteasome system.

41. High dietary advanced glycation end products are associated with poorer spatial learning and accelerated Aβ deposition in an Alzheimer mouse model.

42. AGEs trigger autophagy in diabetic skin tissues and fibroblasts.

43. Antioxidants inhibit advanced glycosylation end-product-induced apoptosis by downregulation of miR-223 in human adipose tissue-derived stem cells.

44. Short-term effects of dietary advanced glycation end products in rats.

45. Alendronate Can Improve Bone Alterations in Experimental Diabetes by Preventing Antiosteogenic, Antichondrogenic, and Proadipocytic Effects of AGEs on Bone Marrow Progenitor Cells.

46. Differences Between Tg2576 and Wild Type Mice in the NMDA Receptor-Nitric Oxide Pathway After Prolonged Application of a Diet High in Advanced Glycation End Products.

47. Formula-derived advanced glycation end products are involved in the development of long-term inflammation and oxidative stress in kidney of IUGR piglets.

48. Effect of an advanced glycation end product-restricted diet and exercise on metabolic parameters in adult overweight men.

49. The influence of body mass index on the accumulation of advanced glycation end products in hemodialysis patients.

50. Myricetin inhibits advanced glycation end product (AGE)-induced migration of retinal pericytes through phosphorylation of ERK1/2, FAK-1, and paxillin in vitro and in vivo.

Catalog

Books, media, physical & digital resources